Search

Search for a security

Equities results (27)

CompanySymbolExchangeCountry
Orpheus Uranium LtdORP:ASXAustralian Stock Exchange LtdAustralia
Orpheus Uranium LtdAGREF:PKCOTC Markets Group Inc - Current InformationUnited States
Orpheus Club Wellness ADOCW:BLGBulgarian Stock ExchangeBulgaria
Orpheus Club Wellness AD0ODD:LSELondon Stock ExchangeUnited Kingdom
Swedish Orphan Biovitrum AB (publ)SOBI:STOOMX Nordic Exchange StockholmSweden
Swedish Orphan Biovitrum AB (publ)0MTD:LSELondon Stock ExchangeUnited Kingdom
Swedish Orphan Biovitrum AB (publ)B6E:BERBerlin Stock ExchangeGermany
Swedish Orphan Biovitrum AB (publ)B6E:MUNMunich Stock ExchangeGermany
Swedish Orphan Biovitrum AB (publ)B6E:FRAGerman Stock ExchangeGermany
Swedish Orphan Biovitrum AB (publ)BVT:DEUGerman CompositeGermany
Swedish Orphan Biovitrum AB (publ)BIOVF:PKLOTC Markets Group Inc - Limited InformationUnited States
Swedish Orphan Biovitrum AB (publ)B6E:STUStuttgart Stock ExchangeGermany
Swedish Orphan Biovitrum AB (publ)SOBIs:EBTEuronext Block
Swedish Orphan Biovitrum AB (publ)SOBIN:MEXMexico Stock ExchangeMexico
Swedish Orphan Biovitrum AB (publ)B6E:DUSDusseldorf Stock ExchangeGermany
Swedish Orphan Biovitrum AB (publ)B6E:HANHanover Stock ExchangeGermany
Swedish Orphan Biovitrum AB (publ)SWOBY:PKLOTC Markets Group Inc - Limited InformationUnited States
Swedish Orphan Biovitrum AB (publ)1SOBI:MILBorsa Italia MTA (Equities)Italy
hVIVO PLCCROG:DEUGerman CompositeGermany
hVIVO PLCCRO:BERBerlin Stock ExchangeGermany
Strategic Partners A/SSTRAP:CPHCopenhagen Stock ExchangeDenmark
Strategic Partners A/S0CUM:LSELondon Stock ExchangeUnited Kingdom
Strategic Partners A/S1TB0:BERBerlin Stock ExchangeGermany
Strategic Partners A/S1TB0:MUNMunich Stock ExchangeGermany
Strategic Partners A/S1TB0:DEUGerman CompositeGermany
Strategic Partners A/S1TB0:FRAGerman Stock ExchangeGermany
Strategic Partners A/S1TB0:STUStuttgart Stock ExchangeGermany
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.